Q1 2018

Filed May 15, 2018 · 10-Q · 45 days after period end · 0001213900-18-006225

Q1 2018 · 10-Q

Revenue

$13.32K

+79.1% vs Q1 2017

Net Income

-$29.61K

N/M vs Q1 2017

EPS Diluted

$0.00

N/M vs Q1 2017

Gross Profit-$1,933N/M

Operating Income

Same quarter

Metric	Q1 2018	Q1 2017	Q1 2016	Q1 2015
Revenue	$13.32K	$7.44K	$31.53K	$62.49K
Net Income	-$29.61K	-$64.59K	-$455.04K	-$39.06K
EPS Diluted	$0.00	-$0.03	-$0.02	-$0.01

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Bioxytran, Inc · CIK 1445815 · Engraved from SEC EDGAR